Dolcanatide

Dolcanatide is an orally active GC-C (guanylate cyclase-C) agonist. Dolcanatide shows laxative, anti-nociceptive and anti-inflammatory activity. Dolcanatide can be used in inflammatory bowel disease research[1][2].

Product Specifications

CAS Number

[1092457-65-2]

UNSPSC

12352209

Target

Guanylate Cyclase

Type

Peptides

Related Pathways

GPCR/G Protein

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/dolcanatide.html

Purity

99.20

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C([C@H](CCC(O)=O)NC([C@H](CC(O)=O)NC([C@H](N)CC(N)=O)=O)=O)N[C@](CSSC[C@@](NC([C@@H](NC([C@@H](NC1=O)C(C)C)=O)C)=O)([H])C(N[C@@](C(NCC(N2)=O)=O)([H])[C@H](O)C)=O)([H])C(N[C@H](C(N[C@@](C(N[C@](CSSC[C@H]2C(N[C@@H](C(O)=O)CC(C)C)=O)([H])C(N[C@H](C(N[C@H]1CC(N)=O)=O)C(C)C)=O)=O)([H])CC(C)C)=O)CCC(O)=O)=O

Molecular Formula

C65H104N18O26S4

Molecular Weight

1681.89

References & Citations

[1]Boulete IM, et al. Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity via activation of guanylate cyclase-C in rat models. World J Gastroenterol. 2018 May 7;24 (17) :1888-1900.|[2]Shailubhai K, et al. Plecanatide and dolcanatide, novel guanylate cyclase-C agonists, ameliorate gastrointestinal inflammation in experimental models of murine colitis. World J Gastrointest Pharmacol Ther. 2015 Nov 6;6 (4) :213-22.